
S748 Early PRO-2 Symptom Remission Following Guselkumab Induction Treatment: Results Through Week 12 of the Phase 2 GALAXI 1 Study
Author(s) -
Anita Afzali,
William J. Sandborn,
Tadakazu Hisamatsu,
Kathleen Weisel,
Susana Gonzalez,
Mary Ellen Frustaci,
Zijiang Yang,
Jewel Johanns,
Matthew Germinaro,
Chenglong Han,
Jane M. Andrews,
Brian G. Feagan,
Walter Reinisch
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776524.51669.ed
Subject(s) - medicine , gastroenterology , abdominal pain , cohort , interim analysis , randomization , corticosteroid , randomized controlled trial , surgery